Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

28%

5 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (2)
P 1 (1)
P 2 (3)
P 3 (2)
P 4 (3)

Trial Status

Completed8
Unknown6
Not Yet Recruiting3
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07505446Not Yet Recruiting

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

NCT07486024Phase 3Not Yet Recruiting

Feasibility of the Application of a New Six-month Treatment for Multidrug-resistant Tuberculosis (MDR-TB) Patients in France (FAST-MDR)

NCT07176247Enrolling By Invitation

Real-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused by Multidrug-resistant Gram-negative Bacteria

NCT04750655Phase 4CompletedPrimary

Antibiotic Resistance In Eye Surgeries

NCT06371560Not Yet RecruitingPrimary

Antibiotics, Antibiotic Resistance, and Prescribing Practices Among Periodontists: Cross Sectional KAP Study

NCT04028830Not ApplicableCompletedPrimary

Impact on Antibiotic Prescriptions of a Bundle Intervention Conducted by Medical Representatives in General Practitioner Facilities, Based on Operational Demonstration of an Internet Decision Support Tool: Antibioclic

NCT05195866Not ApplicableCompletedPrimary

CRP for Respiratory Diagnosis in Kyrgyz Pediatric Practice

NCT05606627Unknown

Correlation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired Pneumonia

NCT04544072Unknown

Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards

NCT03174236Phase 3Unknown

First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition

NCT02591901Phase 2Completed

Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)

NCT03790254Completed

D Mannose for Prevention and Treatment of RUTIs

NCT01321606Phase 2CompletedPrimary

Impact of Probiotics for Reducing Infections in Veterans: The IMPROVE Study

NCT02566928Phase 4Unknown

Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence

NCT00933556Phase 2CompletedPrimary

A Pilot Trial to Determine the Efficacy of VSL#3 for Reducing Colonization by VRE

NCT02367339UnknownPrimary

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff

NCT00874887Phase 4CompletedPrimary

A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms

NCT00722410Phase 1UnknownPrimary

Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia

Showing all 18 trials

Research Network

Activity Timeline